CAM
NVO

CenterStar Asset Management’s Novo Nordisk NVO Stock Holding History

CenterStar Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,900
Closed -$621K – 452
2026
Q1 		$621K Buy
+16,900
New +$801K 0.08% 281

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

CenterStar Asset Management's NVO Position: Q2 2026 in Review

CenterStar Asset Management sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 16,807 shares — an estimated $617K sold.

CenterStar Asset Management first reported a position in NVO in Q1 2026 and held it in 1 quarter. The position peaked at $617K in Q1 2026. 819 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • CenterStar Asset Management reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • CenterStar Asset Management sold 16,807 Novo Nordisk shares in Q2 2026, an estimated $617K.
  • CenterStar Asset Management first reported a position in Novo Nordisk in Q1 2026 and held it in 1 quarter.
  • CenterStar Asset Management's Novo Nordisk position peaked at $617K in Q1 2026.
  • 819 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on CenterStar Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.